Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022
Upgrades
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Harpoon rapeutics
Analyst Ratings for Harpoon Therapeutics
Analysts have provided the following ratings for Harpoon Therapeutics (NASDAQ:HARP) within the last quarter:
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Organisations
Netflix
43,721 stories
Nasdaq
22,872 stories
NYSE
19,916 stories
Goldman Sachs
2,797 stories
Morgan Stanley
2,069 stories
UBS
1,087 stories
NIO
893 stories
JP Morgan
757 stories
Wedbush
602 stories
Baidu
431 stories
RBC Capital
225 stories
JDcom
196 stories
B of A Securities
173 stories
Baird
162 stories
Twilio
147 stories
Cigna
136 stories
SoFi Technologies
133 stories
BMO Capital
132 stories
Trade Desk
126 stories
RH
123 stories
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
